The critical impact of controlled drug delivery in the future of tissue engineering

Trends in Biomaterials and Artificial Organs

Volumn 28, Issue 3, 2014, Pages 124-126

  Mozafari, Masoud ^a  

^a MATERIALS AND ENERGY RESEARCH CENTER   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CONTROLLED DRUG DELIVERY; HISTOLOGY; SCAFFOLDS (BIOLOGY); TISSUE; TISSUE ENGINEERING;

BIOLOGICAL MOLECULE; CONTROLLED DELIVERY; DIFFERENT EFFECTS; LOCALIZED DELIVERY; POLYMERIC SYSTEMS; STATE OF THE ART; TISSUE ENGINEERING APPLICATIONS; TISSUE GROWTH;

TISSUE REGENERATION;

EID: 85010339404     PISSN: 09711198     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Biondi, M., Ungaro, F., Quaglia, F., Netti, P.A., Controlled drug delivery in tissue engineering, Advanced Drug Delivery Reviews, 2008;60 (2), pp. 229-242
2. DocumentShi, J., Votruba, A.R., Farokhzad, O.C., Langer, R., Nanotechnology in drug delivery and tissue engineering: From discovery to applications, Nano Letters, 2010;10 (9), pp. 3223-3230
3. Williams J, Lansdown R, Sweitzer R, et al. Nanoparticle drug delivery system for intravenous delivery of topoisomerase inhibitors. J Control Release 2003;91:167-72.
4. Leroux J-C, Allemann E, De Jaeghere F, Duelker E, Gurny R. Biodegradable nanoparticles-From sustained release formulation to improved site specific drug delivery. J Control Release 1996;30:339-50.
5. Ringdorf H. Structure and properties of pharmacologically active polymers. J Polym Sci Symp 1975; 51:135-53.
6. Hélder A. Santos, Porous-based biomaterials for tissue engineering and drug delivery applications, Biomatter 2012; 2:237-238.
7. Moreno-Vega A., Gómez-Quintero T., Nuñez-Anita R., Acosta-Torres L., Castaño V., Polymeric and Ceramic Nanoparticles in Biomedical Applications, J. Nanotech., Article ID 936041, (2012) doi:10.1155/2012/936041
8. Daniel S Kohane, Robert Langer, Polymeric Biomaterials in Tissue Engineering, Pediatric Research (2008) 63, 487-491.
9. Raphael Riva, Heloýse Ragelle, Anne des Rieux, Nicolas Duhem, Christine Jerome, and Veronique Preat, Chitosan and Chitosan Derivatives in Drug Delivery and Tissue Engineering, AdvPolymSci (2011) 244: 19-44.
10. Jalali N., Moztarzadeh F., Mozafari M., Asgari S., Motevalian M., Alhosseini S.N., Surface modification of poly(lactide-co-glycolide) nanoparticles by d-α-tocopheryl polyethylene glycol 1000 succinate as potential carrier for the delivery of drugs to the brain, Colloids and Surfaces A: Physicochemical and Engineering Aspects, 392 (2011) 335-342.
11. Langer R., Biomaterials in drug delivery and tissue engineering: one laboratory's experience, Acc Chem Res. 33 (2000) 94-101.
12. Hakkarainen, M., Aliphatic polyesters: abiotic and biotic degradation and degradation products, Adv. Polym. Sci., 2002, 157, 113.
13. Vert, M., Li, S., Garreau, H., AJ. More about the degradation of LA/GA-derived matrices in aqueous media, Control. Release., 1991, 16, 15.
14. Park JH, Saravanakumar G et al (2010) Targeted delivery of low molecular drugs using chitosan and its derivatives. Adv Drug Deliv Rev 62:28-41.
15. Patricia B. Malafaya, Gabriela A. Silva, Rui L. Reis, Natural-origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications, Advanced Drug Delivery Reviews 59 (2007) 207-233.
16. Jalali N., Moztarzadeh F., Mozafari M., Asgari S., Motevalian M., Alhosseini S.N., Chitosan-surface modified poly(lactide-co-glycolide) nanoparticles as an effective drug delivery system, 18th Iranian Conference on Biomedical Engineering (IEEE), 14-16 December, 2011, Tehran, Iran.
17. Allen TM, Cullis PR, Drug delivery systems: entering the mainstream. Science, 2004;303:1818-1822.
18. Mozafari M., Functional nanomaterials for advanced tissue engineering, Editor: M. Aliofkhazraei, in Handbook of Functional Nanomaterials Volume 4 Properties and Commercialization, NOVA Science Publishers Inc., New York, USA (2013).
19. K. Nazemi, F. Moztarzadeh, N. Jalali, S. Asgari, M. Mozafari, Synthesis and characterization of poly(lactic-co-glycolic) acid nanoparticlesloaded chitosan/bioactive glass scaffolds as a localized delivery system in the bone defects, Biomed Research International, 2014 (2014) 1-9.
20. Petros RA, DeSimone JM, Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov2010;9(8):615-627 .
21. Shi J, Votruba AR, Farokhzad OC, Langer R (2010) Nanotechnology in drug delivery and tissue engineering: from discovery to applications. Nano Lett 10(9):3223-3230 .
22. Danhier, F., Ansorena, E., Silva, J.M., Coco, R., Le Breton, A., Préat, V., J. Control. Release, 2012, 161, 205.
23. Sun C, Lee JSH, Zhang MQ. Magnetic nanoparticles in MR imaging and drug delivery. Adv Drug Deliv Rev 2008;60:1252-65.
24. Christine T. Schwall and Ipsita A. Banerjee, Micro-and Nanoscale Hydrogel Systems for Drug Delivery and Tissue Engineering, Materials 2009;2:577-612.